BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32706978)

  • 1. The evolution of interventional oncology in the 21st century.
    Helmberger T
    Br J Radiol; 2020 Sep; 93(1113):20200112. PubMed ID: 32706978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Assessment of Immune Effects from Interventional Oncology Procedures.
    Hunt SJ; Seraj SM; Alavi A
    PET Clin; 2019 Oct; 14(4):477-485. PubMed ID: 31472745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 4. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.
    Hickey RM; Kulik LM; Nimeiri H; Kalyan A; Kircher S; Desai K; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Nov; 28(11):1487-1494. PubMed ID: 28912090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).
    Guo ZS
    BMC Cancer; 2018 Nov; 18(1):1086. PubMed ID: 30415640
    [No Abstract]   [Full Text] [Related]  

  • 6. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany.
    Quandt D; Seliger B
    Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer treatment of today in view of the Nobel Prize.
    Ullenhag G
    Ups J Med Sci; 2018 Dec; 123(4):205-206. PubMed ID: 30526172
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The revolution of immuno-oncology therapy: specificities for the physicians].
    Dubois M; Ardin C; André F; Scherpereel A; Mortier L
    Med Sci (Paris); 2019 Dec; 35(12):946-948. PubMed ID: 31903898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligometastatic Disease and Interventional Oncology: Rationale and Research Directions.
    Murali N; Ludwig JM; Nezami N; Kim HS
    Cancer J; 2020; 26(2):166-173. PubMed ID: 32205542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of cancer].
    Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
    Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Tumor immunology meets oncology" (TIMO) X, May 23-24, 2014, Halle/Saale, Germany.
    Quandt D; Seliger B
    Cancer Immunol Immunother; 2015 Apr; 64(4):519-26. PubMed ID: 25680628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From New directions in immuno-oncology.
    Romero D
    Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198
    [No Abstract]   [Full Text] [Related]  

  • 14. Immuno-oncology for surgeons.
    Lee SL; Al-Shamkhani A; Mirnezami A
    Br J Surg; 2019 Sep; 106(10):1273-1282. PubMed ID: 31318438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musculoskeletal interventional oncology: current and future practices.
    Cazzato RL; Garnon J; Koch G; Dalili D; Rao PP; Weiss J; Bauones S; Auloge P; de Marini P; Gangi A
    Br J Radiol; 2020 Nov; 93(1115):20200465. PubMed ID: 32783618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forty-five years in oncology, 25 years with Acta Oncologica.
    Glimelius B
    Acta Oncol; 2018 Dec; 57(12):1593-1598. PubMed ID: 30489167
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.
    Orentas RJ; Mackall CL
    Crit Rev Oncog; 2015; 20(3-4):315-27. PubMed ID: 26349422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art.
    Butterfield LH; Disis ML; Fox BA; Kaufman DR; Khleif SN; Wang E;
    J Immunother Cancer; 2018 Dec; 6(1):138. PubMed ID: 30514399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.